Insulin glargine use and breast cancer: a systematic review and meta-analysis
Background: Insulin is widely used in the treatment of diabetes. There is an increasing concern regarding the association between insulin glargine use and breast cancer. Aim: To systematically review the literature on insulin glargine use and breast cancer risk. Methods: A systematic literature se...
Main Authors: | Ibrahim Altedlawi Albalawi, Hyder Osman Mirghani |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2019-03-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | http://www.ephysician.ir/index.php/browse-issues/11/1/1122-7408 |
Similar Items
-
On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01) -
Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01) -
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
by: Jakobsen Marie, et al.
Published: (2012-09-01) -
rDNA insulin glargine U300 – a critical appraisal
by: Wang F, et al.
Published: (2016-12-01) -
The Role of Insulin Glargine and Human Insulin in the Regulation of Thyroid Proliferation Through Mitogenic Signaling
by: Xiaoli Sheng, et al.
Published: (2019-08-01)